triazoles has been researched along with 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernier, JL; Helbecque, N; Henichart, JP; Houssin, R | 1 |
| Ahgren, C; Backro, K; Bell, FW; Cantrell, AS; Clemens, M; Colacino, JM; Deeter, JB; Engelhardt, JA; Hogberg, M; Jaskunas, SR | 1 |
| Engelhardt, P; Högberg, M; Kangasmetsä, J; Noréen, R; Sahlberg, C; Vrang, L; Zhang, H | 1 |
| Balzarini, J; Bird, LE; Diprose, J; Esnouf, RM; Ikemizu, S; Milton, J; Ren, J; Slater, M; Stammers, DK; Stuart, DI; Warren, J | 1 |
| Mao, C; Sudbeck, EA; Uckun, FM; Venkatachalam, TK | 1 |
| Mao, C; Uckun, FM; Venkatachalam, TK | 1 |
| Auwerx, J; Balzarini, J; Bird, LE; De Clercq, E; Karlsson, A; Oberg, B; Ren, J; Stammers, DK; Stevens, M; Van Rompay, AR | 1 |
| D'Cruz, OJ; Uckun, FM | 1 |
| Agrawal, RK; Ravichandran, V | 1 |
| Fassihi, A; Moeinifard, B; Sabet, R | 1 |
| Hong, Y; Rugang, Z; Xiaohe, Z; Xiuqing, S; Yu, Q | 1 |
2 review(s) available for triazoles and 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
| Article | Year |
|---|---|
Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase.
Topics: Amino Acid Substitution; Drug Design; Drug Resistance, Microbial; HIV; HIV Reverse Transcriptase; Humans; Models, Molecular; Mutation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Triazoles | 2000 |
Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Topics: Acquired Immunodeficiency Syndrome; Anti-Retroviral Agents; Chemistry, Pharmaceutical; Drug Design; Drug Industry; HIV; HIV Reverse Transcriptase; Humans; Models, Chemical; Models, Molecular; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors; Thiazoles; Thymine; Triazoles | 2006 |
9 other study(ies) available for triazoles and 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
| Article | Year |
|---|---|
A new bithiazole derivative with intercalative properties.
Topics: Animals; Cattle; Chemical Phenomena; Chemistry; DNA; Hot Temperature; Intercalating Agents; Models, Molecular; Nucleic Acid Conformation; Nucleic Acid Denaturation; Thiazoles; Thymus Gland; Triazoles | 1986 |
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
Topics: Animals; Antiviral Agents; Base Sequence; Benzodiazepines; Brain; Cattle; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; HIV-1; Humans; Imidazoles; Intercalating Agents; Male; Molecular Sequence Data; Pyridines; Rats; Rats, Inbred F344; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Thiourea; Triazoles | 1995 |
Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Blood Proteins; Cell Line; HIV-1; Humans; Microbial Sensitivity Tests; Protein Binding; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Triazoles | 1998 |
Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses.
Topics: Binding, Competitive; Crystallography, X-Ray; Deoxyguanine Nucleotides; DNA Primers; Dose-Response Relationship, Drug; HIV Reverse Transcriptase; Inhibitory Concentration 50; Intercalating Agents; Kinetics; Models, Chemical; Models, Molecular; Protein Binding; Pyridines; Regression Analysis; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thiazoles; Thiourea; Triazoles | 2000 |
Effect of stereo and regiochemistry towards wild and multidrug resistant HIV-1 virus: viral potency of chiral PETT derivatives.
Topics: Anti-HIV Agents; Drug Resistance, Multiple; Drug Stability; HIV-1; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Triazoles | 2004 |
The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
Topics: Amino Acid Sequence; Anti-HIV Agents; Cells, Cultured; Cytopathogenic Effect, Viral; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Thiazoles; Triazoles | 2004 |
Predicting anti-HIV activity of PETT derivatives: CoMFA approach.
Topics: Anti-HIV Agents; Computational Biology; Drug Design; Humans; Models, Molecular; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Static Electricity; Thiazoles; Thiourea; Triazoles | 2007 |
QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
Topics: Enzyme Inhibitors; HIV Reverse Transcriptase; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Thiazoles; Triazoles | 2009 |
Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Topics: Binding Sites; Cell Line; Computer Simulation; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Models, Molecular; Protein Binding; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Thiazoles; Thioacetamide; Triazoles | 2010 |